首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1705655

全球抗生素抗藥性市場按藥物類別、疾病、分銷管道和地區分類

Global Antibiotic Resistance Market, By Drug Class, By Disease, By Distribution Channel, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球抗生素抗藥性市場規模估計為 88.4 億美元，預計到 2032 年將達到 128.6 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 5.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	88.4億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	5.50%	2032年價值預測	128.6億美元

數字。 2025年全球市場佔有率（按地區）

近年來，全球抗生素抗藥性市場經歷了顯著成長。抗生素是用於預防和治療細菌感染的藥物。抗生素可以殺死細菌或阻止其生長。最常使用的抗生素包括青黴素、阿莫西林和頭孢菌素。然而，過去幾十年來，抗生素抗藥性已成為全球公共衛生的重大威脅。當細菌產生抗生素抗藥性時，用於治療由其引起的感染疾病的藥物就會變得無效。這會導致病程延長和死亡率上升。對各類抗生素產生抗藥性的細菌菌株的增加主要是由於抗生素的濫用和過度使用所造成的。導致抗生素抗藥性的其他因素包括缺乏新抗生素的開發、世界許多地方缺乏衛生設施以及國際旅行的增加。如果處理不當，抗生素抗藥性會導致嚴重的健康問題並影響患者的預後。

市場動態：

全球抗生素抗藥性市場的成長受到多種因素的推動，例如抗生素抗藥性病菌感染的盛行率不斷增加、新抗生素開發不足、現有抗生素的濫用和過度使用以及許多新興市場的感染控制有限。然而，替代治療方法的發展和抗生素使用的嚴格規定可能會抑制市場成長。這個市場為專注於開發具有新作用機制的新型抗生素的公司提供了一個機會。主要企業也在探索噬菌體療法、疫苗和單株抗體等替代治療方法來對抗抗生素抗藥性。產學夥伴關係是解決這一迫在眉睫的醫療保健危機的有效途徑。

本研究的主要特點

本報告對全球抗生素抗藥性市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模和年複合成長率(CAGR)，假設基準年為 2024 年。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數對全球抗生素抗藥性市場的主要企業進行了概述。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球抗生素抗藥性市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球抗生素抗藥性市場的各種策略矩陣來促進決策。

公司簡介
- Melinta Therapeutics
- Merck &Co., Inc.
- Allergan
- Pfizer Inc.
- Tetraphase Pharmaceutical, Inc.
- TeamHealth
- Theravance Biopharma
- WOCKHARDT
- Entasis Threapeutics
- Paratek Pharmaceutials, Inc.
- Seres Therapeutics
- Achaogen Inc.
- Basilea Pharmaceutical Ltd.
- Nabriva Threapeutics plc
- NEMESIS BIOSCIENCE LTD.

第 10 章章節

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI6668

Global Antibiotic Resistance Market is estimated to be valued at USD 8.84 Bn in 2025 and is expected to reach USD 12.86 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 8.84 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.50%	2032 Value Projection:	USD 12.86 Bn

Figure. Global Antibiotic Resistance Market Share (%), By Region 2025

Global Antibiotic Resistance Market - IMG1

The global antibiotic resistance market has been witnessing significant growth in recent years. Antibiotics are medicines used to prevent and treat bacterial infections. They either kill bacteria or stop them from multiplying. Some of the most commonly used antibiotics include penicillin, amoxicillin, cephalosporins etc. However, over the past few decades, antibiotic resistance has been emerging as a major public health threat globally. When bacteria become antibiotic resistant, the medicines used to treat the infections they cause become ineffective. This leads to longer illness and increased death rates. The rising prevalence of bacterial strains that are resistant to various antibiotic classes is primarily attributable to misuse and overuse of antibiotics. Other factors that drive antibiotic resistance include the lack of development of new antibiotics, lack of sanitation and hygiene in many parts of the world, increased international travels, etc. If not addressed properly, antibiotic resistance could lead to serious health issues and affect patient outcomes.

Market Dynamics:

The global antibiotic resistance market growth is driven by various factors such as increasing prevalence of antibiotic-resistant bacterial infections, lack of new antibiotic development, misuse and overuse of existing antibiotics, limited infection control in many developing regions, etc. However, the development of alternative treatment options and stringent regulations regarding antibiotic usage could restrain the market growth. The market provides opportunities for companies focusing on the development of novel antibiotics with new mechanisms of action. Key players are also exploring alternative therapeutic approaches like phage therapy, vaccines, monoclonal antibodies etc. to counter antibiotic resistance. Partnerships between industry and academia hold promise to address this looming healthcare crisis.

Key Features of the Study:

This report provides an in-depth analysis of the global antibiotic resistance market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global antibiotic resistance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Melinta Therapeutics, Merck & Co., Inc., Allergan, Pfizer Inc., Tetraphase Pharmaceutical, Inc., Theravance Biopharma, WOCKHARDT, Entasis Threapeutics, Paratek Pharmaceutials, Inc., Seres Therapeutics, Achaogen Inc., Basilea Pharmaceutical Ltd., Nabriva Threapeutics plc, NEMESIS BIOSCIENCE LTD.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global antibiotic resistance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibiotic resistance market

Detailed Segmentation:

Global Antibiotic Resistance Market, By Drug Class
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Cephalosporins
- Others (Combination therapies, etc.)
Global Antibiotic Resistance Market, By Disease
- cUTI (Complicated Urinary Tract Infections)
- CDI (Clostridioides difficile Infection)
- ABSSSI (Acute bacterial skin and skin structure infections)
- HABP (Hospital-acquired bacterial pneumonia)
- CABP (Community-acquired pneumonia)
- cIAI (Complicated intra-abdominal infection)
- Others (BSI (Bloodstream infection), etc.)
Global Antibiotic Resistance Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Antibiotic Resistance Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Melinta Therapeutics
- Merck & Co., Inc.
- Allergan
- Pfizer Inc.
- Tetraphase Pharmaceutical, Inc.
- Theravance Biopharma
- WOCKHARDT
- Entasis Threapeutics
- Paratek Pharmaceutials, Inc.
- Seres Therapeutics
- Achaogen Inc.
- Basilea Pharmaceutical Ltd.
- Nabriva Threapeutics plc
- NEMESIS BIOSCIENCE LTD.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Disease
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising prevalence of infectious diseases
- Advancement in antibiotic resistance diagnosis
- Growing number of R&D activities
Key Highlights
Guidelines for the Temporary Staffing Agency & the Host Employer
Market Trends
PEST Analysis
Investments and Fundings
Mergers, Acquisitions, and Collaborations
Key Services Offered
Identification of Top Market Players
Nurse Staffing Dominance
Healthcare Spending by Country

4. Global Antibiotic Resistance Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Antibiotic Resistance Market, By Drug Class, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oxazolidinones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Lipoglycopeptides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Cephalosporins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others (Combination therapies, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Antibiotic Resistance Market, By Disease, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
cUTI (Complicated Urinary Tract Infections)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
CDI (Clostridioides difficile Infection)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
ABSSSI (Acute bacterial skin and skin structure infections)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
HABP (Hospital-acquired bacterial pneumonia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
CABP (Community-acquired pneumonia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
cIAI (Complicated intra-abdominal infection)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others (BSI (Bloodstream infection), etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Antibiotic Resistance Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Antibiotic Resistance Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profile
- Melinta Therapeutics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Merck & Co., Inc.
- Allergan
- Pfizer Inc.
- Tetraphase Pharmaceutical, Inc.
- TeamHealth
- Theravance Biopharma
- WOCKHARDT
- Entasis Threapeutics
- Paratek Pharmaceutials, Inc.
- Seres Therapeutics
- Achaogen Inc.
- Basilea Pharmaceutical Ltd.
- Nabriva Threapeutics plc
- NEMESIS BIOSCIENCE LTD.
Analyst Views